GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » Policy Acquisition Expense

Femtobiomed (XKRX:327610) Policy Acquisition Expense


View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Femtobiomed Business Description

Traded in Other Exchanges
N/A
Address
17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487
Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.